

Publisher: Bentham Science Publishers
E-ISSN: 1873-4294|16|7|697-713
ISSN: 1568-0266
Source: Current Topics in Medicinal Chemistry, Vol.16, Iss.7, 2016-03, pp. : 697-713
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Current Topics in Medicinal Chemistry, Vol. 16, Iss. 7, 2016-03 ,pp. :


Targeting Epigenetic Modifiers in Cancer
Current Medicinal Chemistry, Vol. 14, Iss. 24, 2007-10 ,pp. :




Epigenetic Targeting of Platinum Resistant Testicular Cancer
Current Cancer Drug Targets, Vol. 16, Iss. 9, 2016-10 ,pp. :


Clinical Advances in Hypomethylating Agents Targeting Epigenetic Pathways
Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-01 ,pp. :